Page last updated: 2024-08-16

phenylpropanolamine and Parkinson Disease

phenylpropanolamine has been researched along with Parkinson Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YL; Feng, WJ; Zhang, XL1
Edwards, KR; O'Connor, JT1
Alberca, R; Barrero, R; Campoy, P; Cayuela, A; Mir, P; Pena, JM1

Trials

1 trial(s) available for phenylpropanolamine and Parkinson Disease

ArticleYear
[Parkinson's disease combined with overactive bladder syndrome treated with acupuncture and medication].
    Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2012, Volume: 32, Issue:3

    Topics: Adult; Aged; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Electroacupuncture; Female; Humans; Male; Middle Aged; Parkinson Disease; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive

2012

Other Studies

2 other study(ies) available for phenylpropanolamine and Parkinson Disease

ArticleYear
Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors.
    Journal of the American Geriatrics Society, 2002, Volume: 50, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Benzhydryl Compounds; Cholinesterase Inhibitors; Cresols; Delirium; Drug Interactions; Female; Humans; Male; Muscarinic Antagonists; Parkinson Disease; Phenylpropanolamine; Tolterodine Tartrate

2002
[Urinary symptoms and urodynamic findings in Parkinson's disease].
    Neurologia (Barcelona, Spain), 2007, Volume: 22, Issue:2

    Topics: Aged; Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Parkinson Disease; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics

2007